SpectrumAi, a Los Angeles, CA-based company developing solutions to improve autism care, raised up to $20M in Series A funding.
The round was led by CVS Health Ventures with participation from Cobalt Ventures, F-Prime, Frist Cressey and Autism Impact Fund.
Led by CEO Ling Shao, Founder & CEO, SpectrumAi develops solutions to improve life-changing therapies. Its initial focus is to modernize Applied Behavior Analysis (ABA) for children with autism by capturing and measuring objective treatment and outcomes data to understand quality drivers.
The company intends to use the funds to accelerate adoption of its applied behavior analysis (ABA) electronic health record, Twyll, and Patterns, its network analytics platform, which are designed to improve data capture and objective measurement of ABA therapy for autism.
